266 related articles for article (PubMed ID: 31064275)
1. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
2. Genetic Analysis of Ring Finger Protein 213 (RNF213) c.14576G>A in Intracranial Atherosclerosis of the Anterior and Posterior Circulations.
Shinya Y; Miyawaki S; Imai H; Hongo H; Ono H; Takenobu A; Nakatomi H; Teraoka A; Saito N
J Stroke Cerebrovasc Dis; 2017 Nov; 26(11):2638-2644. PubMed ID: 28797616
[TBL] [Abstract][Full Text] [Related]
3. The Clinical and Vascular Characteristics of RNF213 c.14576G>A Variant-Related Intracranial Major Artery Disease in China.
Cheng W; Xue S; Wu F; Song X; Huang Q; Song H; Wu J
Behav Neurol; 2019; 2019():7908392. PubMed ID: 30992731
[TBL] [Abstract][Full Text] [Related]
4. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
[TBL] [Abstract][Full Text] [Related]
5. Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease.
Ishisaka E; Watanabe A; Murai Y; Shirokane K; Matano F; Tsukiyama A; Baba E; Nakagawa S; Tamaki T; Mizunari T; Tanikawa R; Morita A
Neurosurg Focus; 2021 Sep; 51(3):E2. PubMed ID: 34469872
[TBL] [Abstract][Full Text] [Related]
6. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
7. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.
Huang Y; Cheng D; Zhang J; Zhao W
J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544
[TBL] [Abstract][Full Text] [Related]
8. Role of Ring Finger Protein 213 in Moyamoya Disease.
Ma YG; Zhang Q; Yu LB; Zhao JZ
Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
[TBL] [Abstract][Full Text] [Related]
9. Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Mukasa A; Nakatomi H; Shimizu T; Saito N
Stroke; 2013 Oct; 44(10):2894-7. PubMed ID: 23970789
[TBL] [Abstract][Full Text] [Related]
10. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
[TBL] [Abstract][Full Text] [Related]
11. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion.
Miyawaki S; Imai H; Takayanagi S; Mukasa A; Nakatomi H; Saito N
Stroke; 2012 Dec; 43(12):3371-4. PubMed ID: 23010677
[TBL] [Abstract][Full Text] [Related]
12. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
13. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
14. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.
Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N
Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813
[TBL] [Abstract][Full Text] [Related]
15.
Murai Y; Ishisaka E; Watanabe A; Sekine T; Shirokane K; Matano F; Nakae R; Tamaki T; Koketsu K; Morita A
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680863
[TBL] [Abstract][Full Text] [Related]
16. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya Disease and Spectrums of RNF213 Vasculopathy.
Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A
Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369
[TBL] [Abstract][Full Text] [Related]
18. [Precision Medicine for Moyamoya Disease].
Fujimura M
No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
[TBL] [Abstract][Full Text] [Related]
19. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
[TBL] [Abstract][Full Text] [Related]
20. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
